Home›Companies›Healthcare›Promaxo

Promaxo Holdings, Inc.

MRI systems that help clinicians guide prostate biopsies.

Updated Nov 10, 2026·Latest SEC filing Mar 30, 2026·Suggest an edit

About Promaxo

Promaxo is a private company based in Oakland, California, incorporated in 2024 in Delaware. It has reported $26,848,795 raised in one offering on Form D since March 2026. Its chief executive is Amit Vohra.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 17, 2026Mar 30, 2026$26,848,795of $28.7M target118$227KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Promaxo's Form D filed Mar 30, 2026.

Michael Bartholomew
Michael Bartholomew
Secretary of the Board
Also an executive officer and director at Promaxo.
DC
Dushyant Chipalkatty
Director
Also a director at Promaxo.
DH
Derek Hennecke
Director
Also a director at Promaxo.
Amit Vohra
Amit Vohra
CEO and director
Also CEO and director at Neuro42 and Promaxo.

Sources

  1. SECPromaxo Holdings, Inc. filing history
  2. CompanyPromaxo privacy policy
  3. CompanyAbout Promaxo